CN
Connect Biopharma Holdings Limited
CNTB · NASDAQ
$2.06 +3.52% (+$0.07)
1M -11.59%
Market Cap $129.7M
P/E Ratio -
Div. Yield -
ROE 95.51%
Bulios Fair Price
$1.03
50.0% downside
Trenutna cena
$2.06
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CNTB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
33 /100
Expensive P/B 3.09x
P/S 2,026.65x
PEG N/A
Growth
0 /100
Declining Book val. growth 35.64%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak FCF margin 80,687.50%
Op. margin 90,740.60%
Gross margin 100.00%
Quality
0 /100
Poor Asset turnover 0.00x
ROA 98.94%
ROIC 136.22%
Debt
100 /100
Low Current ratio 3.74x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 196.78%
Profitable years 0
Beta -0.22x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CNTB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Barry D. Quart
Employees
64
Headquarters
San Diego
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report